A detailed history of Tbh Global Asset Management, LLC transactions in Alvotech stock. As of the latest transaction made, Tbh Global Asset Management, LLC holds 30,500 shares of ALVO stock, worth $383,080. This represents 0.08% of its overall portfolio holdings.

Number of Shares
30,500
Previous 33,500 8.96%
Holding current value
$383,080
Previous $407,000 11.06%
% of portfolio
0.08%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$10.76 - $12.99 $32,280 - $38,970
-3,000 Reduced 8.96%
30,500 $362,000
Q2 2024

Aug 02, 2024

BUY
$11.4 - $14.51 $381,900 - $486,085
33,500 New
33,500 $407,000

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $3.12B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Tbh Global Asset Management, LLC Portfolio

Follow Tbh Global Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tbh Global Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tbh Global Asset Management, LLC with notifications on news.